Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD

Journal of the American Society of Nephrology

Volumn 23, Issue 10, 2012, Pages 1635-1640

  Carpentier, Eric ^a   Greenbaum, Larry A ^b   Rochdi, Driss ^a   Abrol, Ravinder ^c   Goddard III, William A ^c   Bichet, Daniel G ^d   Bouvier, Michel ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b EMORY UNIVERSITY   (United States)

^c California Institute of Technology   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLIC AMP; PHENYLALANINE; SATAVAPTAN; TOLVAPTAN; VALINE; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INFANT; MEDICAL DECISION MAKING; NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASOPRESSIN BLOOD LEVEL;

EID: 84867157681     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012010077     Document Type: Article

References (22)

1. Ball SG: Vasopressin and disorders of water balance: The physiology and pathophysiology of vasopressin. Ann Clin Biochem 44: 417-431, 2007
2. Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001
3. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE: Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352: 1884-1890, 2005 (Pubitemid 40627814)
4. Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M: Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol 77: 836-845, 2010
5. Tenenbaum J, Ayoub MA, Perkovska S, Adra-Delenne AL, Mendre C, Ranchin B, Bricca G, Geelen G, Mouillac B, Durroux T, Morin D: The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation. PLoS ONE 4: e8383, 2009
6. Kocan M, See HB, Sampaio NG, Eidne KA, Feldman BJ, Pfleger KD: Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23: 559-571, 2009
7. Hanna S, Tibby SM, Durward A, Murdoch IA: Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr 92: 430-434, 2003 (Pubitemid 37098301)
8. Kocan M, See HB, Sampaio NG, Eidne KA, Feldman BJ, Pfleger KD: Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23: 559-571, 2009
9. Hamdan FF, Rochdi MD, Breton B, Fessart D, Michaud DE, Charest PG, Laporte SA, Bouvier M: Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2. J Biol Chem 282: 29089-29100, 2007 (Pubitemid 350043377)
10. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Piñeyro G: Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A 100: 11406-11411, 2003 (Pubitemid 37205948)
11. Galandrin S, Oligny-Longpré G, Bouvier M: The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28: 423-430, 2007 (Pubitemid 47087968)
12. Violin JD, Lefkowitz RJ: Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28: 416-422, 2007
13. Abrol R, Griffith AR, Bray JK, Goddard WA 3rd: Structure Prediction of G Protein-Coupled Receptors and Their Ensemble of Functionally Important conformations. In: Membrane Protein Structure: Methods and Protocols (Methods in Molecular Biology). Edited by Vaidehi N, Klein-Seetharaman J, New York, Humana, Vol. 914, pp. 237-254
14. Abrol R, Kim SK, Bray JK, Griffith AR, Goddard WA 3rd: Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins. Methods 55: 405-414, 2011
15. Morin D, Cotte N, Balestre MN, Mouillac B, Manning M, Breton C, Barberis C: The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett 441: 470-475, 1998 (Pubitemid 29065337)
16. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C: Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18: 606-612, 2007 (Pubitemid 46193326)
17. Ghali JK, Hamad B, Yasothan U, Kirkpatrick P: Tolvaptan. Nat Rev Drug Discov 8: 611-612, 2009
18. Zerbe R, Stropes L, Robertson G: Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31: 315-327, 1980
19. Charest PG, Bouvier M: Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation. J Biol Chem 278: 41541-41551, 2003 (Pubitemid 37280984)
20. Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105: 887-895, 2000 (Pubitemid 30203061)
21. Bockenhauer D, Carpentier E, Rochdi D, Van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG: Vasopressin type 2 receptor V88M mutation: Molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 114: p1-p10, 2009
22. Breton B, Sauvageau E, Zhou J, Bonin H, Le Gouill C, Bouvier M: Multiplexing of multicolor bioluminescence resonance energy transfer. Biophys J 99: 4037-4046, 2010